Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study.

Cardiovasc Diabetol · 2025 · PMC11846359 · PMID 39985069

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

showed a trendp -value = 0.063so close (0.05 < p ≤ 0.1)

No significant differences were observed in other cardiovascular surrogates calculated from quantitative characteristics of lipoproteins, but the HDL-C-to-total triglycerides showed a trend ( p -value = 0.063) towards being decreased in the CVE group compared with the non-CVE group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.